Research Paper Volume 13, Issue 5 pp 6702—6711

The impact of visceral obesity on chronic constipation, inflammation, immune function and cognitive function in patients with inflammatory bowel disease

Impact of visceral obesity on IL-6 in patients with Crohn’s disease. CD patients with visceral obesity had higher level of IL-6 compared with CD patients without visceral obesity (15.28 ± 10.54 pg/ml, n=37 vs. 9.429 ± 6.94 pg/ml, n=35, P = 0.007).

Figure 3. Impact of visceral obesity on IL-6 in patients with Crohn’s disease. CD patients with visceral obesity had higher level of IL-6 compared with CD patients without visceral obesity (15.28 ± 10.54 pg/ml, n=37 vs. 9.429 ± 6.94 pg/ml, n=35, P = 0.007).